Henry Lee Cooper, who serves as a director at Lumexa Imaging Holdings, Inc. (NASDAQ:LMRI), executed a notable purchase of the company's common stock on May 14, 2026. The transaction involved acquiring 30,000 shares, totaling $223,113 in value.
These shares were acquired through several transactions, with the prices observed ranging between $7.32 and $7.50 per share. Notably, these purchase prices were higher than the stock's reported current price of $6.77. For context, data from InvestingPro indicates that the stock is currently trading near its 52-week low of $6.45 after experiencing a decline exceeding 30% within the past week.
Despite the recent downward trend in the market, InvestingPro analysis suggests that the stock may be undervalued, assigning it a Fair Value estimate of $8.8. This valuation places LMRI on the list of most undervalued stocks. The shares purchased by Mr. Cooper are held indirectly by the Cooper Family Trust, which is structured as a revocable trust and names both Mr. Cooper and his spouse as co-trustees. Following this specific transaction, the trust now holds 30,000 shares of Lumexa Imaging Holdings, Inc.'s common stock.
The recent executive activity is set against a backdrop of other corporate developments for Lumexa Imaging Holdings Corp. The company recently released its Q1 2026 earnings report. According to the filing, the firm achieved an adjusted earnings per share (EPS) of $0.18 and reported revenues totaling $253 million.
The revenue figures indicate a 3% year-over-year growth for Lumexa. This level of performance demonstrates a degree of resilience within the company's operations, even while facing disruptions that were attributed to seasonal and weather-related factors. While these financial results successfully met analyst projections, they arrived amidst significant operational challenges.
Furthermore, regarding corporate governance and market sentiment, recent developments show that there have been no announcements concerning mergers or acquisitions involving the company. Similarly, there has been no reporting of any recent analyst upgrades or downgrades for Lumexa Imaging Holdings Corp. These various elements provide a current view of the firm's standing and its performance within the broader market.
Key Insights from Insider Activity and Corporate Performance
The combination of insider buying and routine operational reporting provides several data points regarding corporate health and investor perception.
-
Risks
- Market volatility and decline near 52-week lows.
- Reliance on meeting expectations amid seasonal/weather disruptions.
- Lack of recent analyst coverage updates may limit immediate market visibility.
More from Insider Trading